Loading organizations...
Pacific Horizon Ventures operates as a venture capital firm, focusing investments on early-stage life science technologies. The firm provides capital and strategic support to companies developing innovative solutions within the life sciences. Its core capability involves identifying and cultivating promising ventures that demonstrate strong potential for significant value creation.
Donald J. Elmer, the Managing General Partner, founded the firm in 1993. Leveraging his prior experience as an active venture investor and early-stage entrepreneur dating back to 1980, Elmer established Pacific Horizon Ventures. This foundation reflected an understanding of the specific capital needs and growth potential inherent in nascent life science companies.
The firm's clients are early-stage life science companies. Pacific Horizon Ventures’ vision is to construct a successful portfolio that achieves financial returns and contributes meaningfully to scientific and medical progress. It aims to enable its partner companies to bring their innovative solutions to market effectively.
Pacific Horizon Ventures has 2 tracked investments across 1 company. The latest tracked deal is $25.0M Other Equity in ViaCyte in July 2007.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 20, 2007 | ViaCyte | $25.0M Other Equity | Johnson & Johnson Innovation | Asset Management, Sanderling Ventures |
| Jul 1, 2007 | ViaCyte | $25.0M Series C | Johnson & Johnson Innovation | Chris, Morgenthaler Ventures, Asset Management, Sanderling Ventures |
